Evaluation of GITRL coexpression on the therapeutic efficiency and immunossupressi...
Evaluation of the therapeutic efficacy of anti-GD2 CAR-NK cells with GITRL express...
Multi-user equipment approved in grant 2021/10265-8: nCounter® Pro analysis system
Cell therapy with macrophages and NK cells modulated ex vivo by peptide isolated f...
Genetic modification of NK cells with anti-CD19 CAR expressing GITRL to increase N...
Regenerative medicine aiming at therapy for chronic degenerative diseases (cancer ...